Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Duncan Disease

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Duncan Disease in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research Excerpts

ExcerptRelevanceReference
"A diagnosis of limbic encephalitis was made."1.72Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody. ( Abe, Y; Gocho, Y; Hamano, S; Hayakawa, I; Hogetsu, K; Miyata, Y; Ochiai, S; Ogura, M; Ohashi, E; Sakuma, H; Uchiyama, T, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ochiai, S1
Hayakawa, I1
Ohashi, E1
Hamano, S1
Miyata, Y1
Sakuma, H1
Hogetsu, K1
Gocho, Y1
Ogura, M1
Uchiyama, T1
Abe, Y1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Duncan Disease

ArticleYear
Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody.
    Brain & development, 2022, Volume: 44, Issue:9

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Child; Epstein-Barr Virus

2022